What is he best known for?
The fields of study he is best known for:
- Enzyme
- Internal medicine
- Receptor
Internal medicine, Endocrinology, Receptor, Muscarinic acetylcholine receptor and Pharmacology are his primary areas of study.
His Internal medicine study incorporates themes from Neuroscience and Binding site.
His Endocrinology study combines topics in areas such as Neuropeptide, Substance P and Spinal cord.
His study ties his expertise on Stereochemistry together with the subject of Receptor.
His work in Muscarinic acetylcholine receptor covers topics such as Acetylcholine which are related to areas like Choline, Hippocampal formation, Glutamate receptor and Biophysics.
His Pharmacology research incorporates elements of Potency, Muscarinic acetylcholine receptor M4, gamma-Aminobutyric acid and Benzodiazepine.
His most cited work include:
- Muscarinic Cholinergic Binding in Rat Brain (1091 citations)
- Drugs, neurotransmitters, and schizophrenia. (731 citations)
- Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. (624 citations)
What are the main themes of his work throughout his whole career to date?
Henry I. Yamamura focuses on Receptor, Internal medicine, Endocrinology, Pharmacology and Stereochemistry.
His Receptor study is concerned with the field of Biochemistry as a whole.
Many of his studies on Internal medicine apply to Neuroscience as well.
His Endocrinology research is multidisciplinary, incorporating elements of Muscarinic acetylcholine receptor and Binding site.
His biological study spans a wide range of topics, including Antagonist and GABAA receptor, Benzodiazepine, Flunitrazepam.
His studies in Stereochemistry integrate themes in fields like Ligand, μ-opioid receptor, Biological activity, δ-opioid receptor and Peptide.
He most often published in these fields:
- Receptor (42.15%)
- Internal medicine (35.67%)
- Endocrinology (35.32%)
What were the highlights of his more recent work (between 1997-2017)?
- Receptor (42.15%)
- Opioid receptor (10.92%)
- Stereochemistry (23.38%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Receptor, Opioid receptor, Stereochemistry, Agonist and Biochemistry.
His Receptor study contributes to a more complete understanding of Internal medicine.
The concepts of his Opioid receptor study are interwoven with issues in Ligand binding assay, Pharmacology, G protein and Enkephalin.
The Pharmacology study which covers Opioid that intersects with Analgesic, Signal transduction and Neuroscience.
The Stereochemistry study combines topics in areas such as Amino acid, Opioid peptide, Biological activity and Peptidomimetic, Peptide.
His Agonist study combines topics in areas such as Pharmacophore and G protein-coupled receptor.
Between 1997 and 2017, his most popular works were:
- The δ-Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy (153 citations)
- Enkephalin Glycopeptide Analogues Produce Analgesia with Reduced Dependence Liability (113 citations)
- Improved bioavailability to the brain of glycosylated Met-enkephalin analogs (103 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Gene
Henry I. Yamamura mainly investigates Receptor, Opioid receptor, Agonist, Stereochemistry and Pharmacology.
The subject of his Receptor research is within the realm of Internal medicine.
His Internal medicine research incorporates elements of Protein kinase A and Mechanism of action.
His Opioid receptor research includes themes of Signal transduction, Ligand binding assay and Enkephalin.
His Stereochemistry research includes elements of Bilayer, Lipid bilayer, Peptide and Ligand.
His work deals with themes such as Endomorphin-1 and Partial agonist, which intersect with Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
